X
https://tiefenbachergroup.com/2023/05/10/successful-approval-of-manufacturing-and-laboratory-facilities-by-saudi-food-and-drug-authority/
https://tiefenbachergroup.com/2023/03/14/new-market-launch-tiefenbacher-pharmaceuticals-successfully-launches-the-antihistamine-bilastine-for-a-market-entry-as-over-the-counter-otc-medicine-in-germany/
https://tiefenbachergroup.com/2023/02/25/tiefenbacher-groups-manufacturing-sites-have-been-successfully-registered-by-the-united-arab-emirates-ministry-of-health/
https://tiefenbachergroup.com/2022/12/01/new-market-launch-tiefenbacher-pharmaceuticals-successfully-launches-generic-version-of-the-psoriasis-medication-apremilast-in-canada/
https://tiefenbachergroup.com/2022/09/15/meet-tiefenbacher-group-at-bepharma-in-mexico-city-from-october-10-12/
https://www.ema.europa.eu/en/documents/overview/pirfenidone-aet-epar-medicine-overview_en.pdf
https://www.ema.europa.eu/en/documents/overview/pirfenidone-aet-epar-medicine-overview_en.pdf
https://tiefenbachergroup.com/2022/05/24/tiefenbacher-group-becomes-member-of-the-pharmaceutical-supply-chain-initiative-psci/
https://aet.eu/2022/05/05/tiefenbacher-group-opens-new-site-for-highly-potent-drugs-in-india/
Market Place
Share 
